Receptor News and Research

RSS

Novel peptide receptor radionuclide therapy improves wellbeing of neuroendocrine cancer patients

Malignant neuroendocrine tumors, commonly called NETs, are easy to miss and associated with discouraging survival rates and poor quality of life.

13 Jun 2017

Moffitt researchers develop novel drug that may help combat castration-resistant prostate cancer

Prostate cancer is the third most common cause of cancer-related death in men in the United States. It is estimated that 161,360 men will be diagnosed and more than 26,700 men will die from the disease in this year.

12 Jun 2017

Researchers uncover molecule in newborn hearts that appears to control renewal process

Heart disease remains the leading cause of death worldwide, yet the few available treatments are still mostly unsuccessful once the heart tissue has suffered damage.

9 Jun 2017

Novartis announces data revealing efficacy of new monoclonal antibody therapy in preventing migraine

Novartis today announced that it will present 19 scientific abstracts at the 59th Annual Scientific Meeting of the American Headache Society.

8 Jun 2017

Mammography: Early breast cancer detection could lead to overdiagnosis

An analysis of breast cancer data revealed that many small breast cancers have an excellent prognosis because they are inherently slow growing, according to Yale Cancer Center experts.

8 Jun 2017

SLU scientist discovers cause and potential solution for cancer-related bone pain

In a paper published in the journal Pain, Saint Louis University researcher Daniela Salvemini, Ph.D., reports discovering a key molecular pathway that drives cancer-related bone pain while providing a potential solution with a drug that already is on the market.

8 Jun 2017

Use of cardiovascular medications linked to fall risk in older adults

A new analysis suggests that among older adults who take cardiovascular medications, those using non-selective beta-blockers may be at an increased of falling compared with those using selective beta-blockers.

7 Jun 2017

New immunotherapy sends multiple myeloma into remission

Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.

6 Jun 2017

Researcher discovers treatment strategy to attack metastatic cancers that have spread to the brain

Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported by the National Foundation for Cancer Research, has discovered a novel mechanism behind the resistance to HER2- or PI3K-targeted therapies, and a treatment strategy that may overcome treatment resistance.

6 Jun 2017

Adding a second HER2-targeted treatment may improve outcomes for some women with breast cancer

A phase III clinical trial of 4,805 women with HER2-positive breast cancer suggests adding a second HER2 targeted medicine, pertuzumab (Perjeta), to standard of care trastuzumab (Herceptin) after surgery may help, although the benefit is modest.

6 Jun 2017

Findings point to potential new treatment for people with newly diagnosed EGFR-positive NSCLC

Findings from a phase III clinical trial point to a potential new treatment for patients newly diagnosed with advanced, epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC).

5 Jun 2017

New targeted oral therapy results in durable responses across many kinds of cancer

Scientists may have developed the first targeted, oral, tumor-type agnostic therapy - a cancer medicine that works comparably well across many kinds of cancer, regardless of patient age. In clinical trials of adults and children with 17 different types of advanced cancer, larotrectinib treatment resulted in responses in 76% of patients.

5 Jun 2017

Study provides reassurance to breast cancer survivors who contemplate pregnancy

Findings from a retrospective study of 1,200 women provide reassurance to breast cancer survivors who are contemplating pregnancy.

5 Jun 2017

TSRI study reveals first-ever structure of Lassa virus protein

Before Ebola virus ever struck West Africa, locals were already on the lookout for a deadly pathogen: Lassa virus. With thousands dying from Lassa every year-;and the potential for the virus to cause even larger outbreaks- researchers are committed to designing a vaccine to stop it.

1 Jun 2017

Yale researchers find racial and ethnic disparities in use of genetic test for breast cancer

A genetic test that helps doctors determine how best to treat breast cancer-;and whether chemotherapy is likely to help- is significantly more likely to be administered to white women than blacks or Hispanics, a Yale study has found.

1 Jun 2017

LMU researchers show how genetic variant in people of African ancestry modulates immune cells

A genetic variant that is particularly prevalent in people of African ancestry confers protection against malaria. LMU researchers have now shown how it modulates the properties of white blood cells that play a major role in immune defenses and inflammation.

1 Jun 2017

Sour-sensing taste cells play key role in detecting water on the tongue

New research from Caltech shows that sour-sensing taste cells play an important role in detecting water on the tongue.

1 Jun 2017

Researchers reveal how social laughter leads to endorphin release in the brain

Finnish and British researchers have revealed how laughter releases endorphins in the human brain. The more opioid receptors the participants had in their brain, the more they laughed during the experiment.

1 Jun 2017

Chronic pain may occur when receptors migrate from nerve cell's surface to inner chambers

A study led by Columbia University Medical Center has shown that chronic pain may occur when pain receptors migrate from the nerve cell's surface to the cell's inner chambers, out of the reach of current pain medications.

1 Jun 2017

Researchers uncover new way to enhance function of immune cells to combat multiple myeloma

Researchers from Belgium led by Prof. Dirk Elewaut of the VIB-UGent Center for Inflammation Research and the team of Prof. Vanderkerken and Prof. Menu at the Hematology and Immunology lab of the VUB uncovered a new way to enhance the function of a specific type of immune cell that destroys tumors in multiple myeloma, a form of bone marrow cancer considered incurable.

1 Jun 2017

Receptor News and Research

Novel peptide receptor radionuclide therapy improves wellbeing of neuroendocrine cancer patients

Moffitt researchers develop novel drug that may help combat castration-resistant prostate cancer

Researchers uncover molecule in newborn hearts that appears to control renewal process

Novartis announces data revealing efficacy of new monoclonal antibody therapy in preventing migraine

Mammography: Early breast cancer detection could lead to overdiagnosis

SLU scientist discovers cause and potential solution for cancer-related bone pain

Use of cardiovascular medications linked to fall risk in older adults

New immunotherapy sends multiple myeloma into remission

Researcher discovers treatment strategy to attack metastatic cancers that have spread to the brain

Adding a second HER2-targeted treatment may improve outcomes for some women with breast cancer

Findings point to potential new treatment for people with newly diagnosed EGFR-positive NSCLC

New targeted oral therapy results in durable responses across many kinds of cancer

Study provides reassurance to breast cancer survivors who contemplate pregnancy

TSRI study reveals first-ever structure of Lassa virus protein

Yale researchers find racial and ethnic disparities in use of genetic test for breast cancer

LMU researchers show how genetic variant in people of African ancestry modulates immune cells

Sour-sensing taste cells play key role in detecting water on the tongue

Researchers reveal how social laughter leads to endorphin release in the brain

Chronic pain may occur when receptors migrate from nerve cell's surface to inner chambers

Researchers uncover new way to enhance function of immune cells to combat multiple myeloma

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News